Delivery Order SPE2DB24D6038-SPE2DB25FELRW

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the supply of Albendazole tablets, a common anti-parasitic medication, with a ceiling value of $5,258.40 and a completion date of April 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that...
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $5,258.40 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ALBENDAZOLE TABLETS. This contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,567,308 tablets of Albendazole 200 mg. The contract, valued at $2,393.80, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of February 20, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp is for the delivery of 4561569107 Albendazole 200mg tablets. The single-award delivery order contract has a firm fixed price of $1,839.01 and an ultimate completion date of July 24, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies medical products to federal government agencies, particularly...
The U.S. Defense Logistics Agency Troop Support Medical awarded a $5,258.40 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the provision of Albendazole tablets. The contract has a completion date of February 22, 2024 and was awarded on February 21, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to supply Albendazole 200mg tablets. The $68,255.68 firm-fixed-price delivery order has an ultimate completion date of December 7, 2023. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,051,643 units of the drug Albendazole 200 mg tablets. The $1,809.17 firm fixed-price contract has a completion date of July 3, 2024. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
This is a Delivery Order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,857.07, is for the supply of Albendazole 200 mg tablets. It is a Firm Fixed Price contract with a performance period ending on March 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of Albendazole 200mg tablets and has a ceiling value of $1,483.81. The contract has an ultimate completion date of September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,562.90 firm fixed price contract is for the delivery of Albendazole 200 mg tablets. The contract has an ultimate completion date of October 23, 2023 and was awarded on October 20, 2022. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB24D6038
    Indefinite Delivery Contract
  • SPE2DB24D6038-SPE2DB25FELRW
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albendazole 200 mg tablets. The contract, valued at $1,997.46, has a performance period through January 16, 2025 and was awarded on a Firm Fixed Price basis. This Delivery Order contract is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.

Generated 4/21/25, 3:49 AM